Epidermolysis Bullosa Simplex: Clinical Trials

1 trial for Epidermolysis Bullosa Simplex, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1

Follow Epidermolysis Bullosa Simplex: new trials by email Literature Review of Epidermolysis Bullosa Simplex trials Research Report on Epidermolysis Bullosa Simplex

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of Diacerein 1% Ointment for Subjects With Epidermolysis Bullosa Simplex (EBS)
diacerein 1% ointment, A placebo ointment - Epidermolysis Bullosa Simplex
Phase 2TerminatedCastle Creek Pharmaceuticals, LLC542017-06-012019-11-05

Broader conditions

Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Epidermolysis Bullosa (1)  ·  Genetic Diseases, Inborn (1)  ·  Skin Abnormalities (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Genetic (1)  ·  Skin Diseases, Vesiculobullous (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

Ointments (1)  ·  diacerein (1)

Sponsors

Castle Creek Pharmaceuticals, LLC (1)

Countries

Australia (1)  ·  Austria (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Netherlands (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Mary Spellman, MD (1)